EICHORCondition: Coronary Artery Disease · Sponsor: Elixir Medical Corporation
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The goal of this registry is to confirm the safety, and performance of the DynamX Coronary Bioadaptor System in patients with coronary artery disease.
This description comes directly from the study's public registry record.
Lisa Tanner · +1 408 636 2000 · ltanner@ElixirMedical.com
Elizabeth Lau, PhD · elau@ElixirMedical.com
Always discuss trial participation with your own doctor first.
| University Hospital St. Pölten | Pölten, Austria | Recruiting |
| Curaçao Medical Center | Willemstad, Curacao | Recruiting |
| Heartology Cardiovascular Hospital | Jakarta, Indonesia | Recruiting |
| Jakarta Heart Center | Jakarta, Indonesia | Recruiting |
| Medistra Hospital | Jakarta, Indonesia | Recruiting |
| Siloam Hospitals | Jakarta, Indonesia | Recruiting |
| Centro Cardiologico Monzino | Milan, Italy | Recruiting |
| Azienda Ospedaliera Universitaria "Federico II" | Naples, Italy | Recruiting |
| Policlinico Tor Vergata | Rome, Italy | Recruiting |
| Jordon Hospital | Amman, Jordan | Recruiting |
| The Specialty Hospital | Amman, Jordan | Recruiting |
| King Fahad Armed Forces Hospital | Jeddah, Saudi Arabia | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06074549